Las Vegas, NV -- (SBWIRE) -- 01/09/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Glu Mobile Inc.(NASDAQ:GLUU), EXCO Resources Inc(NYSE:XCO), ReneSola Ltd. (ADR)(NYSE:SOL), Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN)
Glu Mobile Inc.(NASDAQ:GLUU) was a volume gainer of 5.33 million shares and the average volume of the stock remained 2.58 million shares. The stock opened the session at $4.30 and finished at the end of the day at $4.25 and the stock escalated 1.92%.The market capitalization of the stock remained 331.32 million. Glu Mobile Inc. develops and publishes a portfolio of action/adventure and casual games for the users of smartphones and tablet devices. The company develops games based on its own brands, including Blood & Glory, Big Time Gangsta, Contract Killer, Contract Killer: Zombies, Deer Hunter, Eternity Warriors, Frontline Commando, Gun Bros, Samurai vs.
For How Long GLUU will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, EXCO Resources Inc(NYSE:XCO) exchanged 5.30 million shares and the average volume remained 4.27 million shares. The stock closed the session at $5.09 with the gain of 0.39%. EXCO Resources, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, exploitation, development and production of onshore U.S. oil and natural gas properties with a focus on shale resource plays.
Will XCO Continue To Move Higher? Find Out Here
ReneSola Ltd. (ADR)(NYSE:SOL) decreased -1.18% and its closing price was $4.17. The volume of the stock was 5.23 million shares and the average volume remained 4.04 million shares. The market capitalization of the stock remained 423.86 million. The beta of the stock remained 3.17. ReneSola Ltd operates as a brand and technology provider of solar photovoltaic (PV) products. The company, through its subsidiaries, engages in the research and development, and manufacture of virgin polysilicon, monocrystalline and multicrystalline silicon wafers, and PV cells and modules.
Will SOL Get Buyers Even After The Recent Rally? Find Out Here
Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN) exchanged 5.26 million shares in the previous trading session, and its average trading remained 2.04 million shares. ACHN advanced 13.29% and it closed the trading at $3.75. The market capitalization of the stock remained 362.41 million. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection.
For How Long ACHN’s Gloss will Attract Investors? Find out via this report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)